Quick Answer
Decoy Therapeutics Inc. reported Operating Income of -$12.61 million for fiscal year 2025.
Decoy Therapeutics Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$12.61M | -120.0% |
| 2024 | -$5.73M | +55.5% |
| 2023 | -$12.89M | +59.5% |
| 2022 | -$31.84M | -148.5% |
| 2021 | -$12.81M | -64.6% |
| 2020 | -$7.79M | +5.8% |
| 2019 | -$8.27M | -390.6% |
| 2018 | -$1.68M | +95.1% |
| 2017 | -$34.73M | +12.9% |
| 2016 | -$39.89M | -36.5% |
| 2015 | -$29.21M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$895.1K | +11.1% | +7.3% |
| June 30, 2025 | -$965.6K | +34.2% | +43.8% |
| March 31, 2025 | -$1.72M | +3.0% | -70.8% |
| September 30, 2024 | -$1.01M | +60.3% | +31.4% |
| June 30, 2024 | -$1.47M | +63.0% | +17.2% |
| March 31, 2024 | -$1.77M | +67.3% | +30.0% |
| September 30, 2023 | -$2.53M | +82.5% | +36.2% |
| June 30, 2023 | -$3.97M | +16.5% | +26.7% |
- Decoy Therapeutics Inc. showed a decrease of -120.0% in Operating Income compared to the prior fiscal year.
- Over the 2015–2025 period, Decoy Therapeutics Inc.’s operating income has grown by 56.8% (from -$29.21 million to -$12.61 million).
- The most recent figure is from Decoy Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: